HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Allogenic bone marrow transplantation in Wiskott-Aldrich syndrome].

Abstract
Two males of 3 and 3 1/2 years of age with the Wiskott-Aldrich syndrome who underwent bone marrow transplantation from an HLA compatible brother following conditioning treatment with busulphan and cyclophosphamide are described. In both patients the taking of the graft was proven by study of blood subgroups and correction of the immunodeficiency, normalization of platelet number and function and disappearance of cutaneous eczema were seen. At 3 and 1 year respectively of the transplantation the patients showed no evidence of graft versus host disease and no severe infections or hemorrhagic episodes have seen.
AuthorsM S Maldonado, A Muñoz, E Otheo de Tejada, E Roldán, L Aymerich, J A Brieva
JournalMedicina clinica (Med Clin (Barc)) Vol. 101 Issue 7 Pg. 258-60 (Sep 11 1993) ISSN: 0025-7753 [Print] Spain
Vernacular TitleTrasplante de medula ósea alogénico en el síndrome de Wiskott-Aldrich.
PMID7746001 (Publication Type: Case Reports, English Abstract, Journal Article)
Topics
  • Bone Marrow Transplantation
  • Child, Preschool
  • Humans
  • Male
  • Wiskott-Aldrich Syndrome (surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: